Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study. (Q47407413)

15 January 2018

title

Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study. (English)

1 reference

15 January 2018

1 reference

6

1 reference

15 January 2018

author name string

Alberto Verrotti

1

1 reference

15 January 2018

Pasquale Parisi

2

1 reference

15 January 2018

Sergio Agostinelli

3

1 reference

15 January 2018

Giulia Loiacono

4

1 reference

15 January 2018

Francesca Marra

5

1 reference

15 January 2018

Laura Rosa Pisani

7

1 reference

15 January 2018

Gaetano Gorgone

8

1 reference

15 January 2018

Pasquale Striano

9

1 reference

15 January 2018

Francesco Pisani

10

1 reference

15 January 2018

Vincenzo Belcastro

11

1 reference

15 January 2018

publication date

1 February 2015

1 reference

15 January 2018

published in

CNS Drugs

1 reference

15 January 2018

volume

29

1 reference

15 January 2018

page(s)

163-169

1 reference

15 January 2018

issue

2

1 reference

15 January 2018

https://scigraph.springernature.com/pub.10.1007/s40263-015-0229-z

exact match

0 references

cites work

2009 Edward E Smissman Award. Pharmaceutical "gold" from neurostabilizing agents: topiramate and successor molecules

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Antiobesity carbonic anhydrase inhibitors: a literature and patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Weight change associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Topiramate, nutrition and weight change: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Role of antiepileptic drugs in the management of eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

A prospective study of body weight and serum leptin levels in patients treated with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Italian cross-sectional growth charts for height, weight and BMI (6-20 y).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Predictors of Weight Loss in Adults with Topiramate‐Treated Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Effects of antiepileptic drugs on extracellular pH regulation in the hippocampal CA1 region in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Antiobesity carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Topiramate-induced weight loss: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Topiramate: effects on serum lipids and lipoproteins levels in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Effects of topiramate on weight and metabolism in children with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Obesity and headache: Part II--potential mechanism and treatment considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0229-Z

Seasonal variations of glycosylated haemoglobin in diabetic children

21 January 2018

1 reference

12 December 2020

Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment

1 reference

12 December 2020

Long-term weight loss maintenance

1 reference

12 December 2020

Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity

1 reference

12 December 2020

10.1007/S40263-015-0229-Z

Identifiers

DOI

1 reference

15 January 2018

PubMed ID

25655110

1 reference

15 January 2018